| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2571 |
| 1 | METHOTREXATE SODIUM | 1960 |
| 2 | METHOTREXATE | 1697 |
| 3 | INFLIXIMAB | 1458 |
| 4 | PREDNISONE | 1353 |
| 5 | ETANERCEPT | 1205 |
| 6 | INFLIXIMAB-DYYB | 772 |
| 7 | ADALIMUMAB-ADAZ | 758 |
| 8 | SECUKINUMAB | 664 |
| 9 | ADALIMUMAB-AATY | 647 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 772 | 0.2240 |
| 1 | OMIDENEPAG ISOPROPYL | 4 | 0.0606 |
| 2 | PHENYLEPHRINE AND KETOROLAC | 4 | 0.0488 |
| 3 | PEGCETACOPLAN | 80 | 0.0421 |
| 4 | GOLIMUMAB | 504 | 0.0400 |
| 5 | FARICIMAB | 353 | 0.0398 |
| 6 | AFLIBERCEPT-AYYH | 4 | 0.0396 |
| 7 | CYCLOPENTOLATE HYDROCHLORIDE | 25 | 0.0379 |
| 8 | AVACINCAPTAD PEGOL | 12 | 0.0341 |
| 9 | ADALIMUMAB-AFZB | 79 | 0.0294 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 4095 |
| 1 | Corticosteroid [EPC] | 2280 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 1704 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1315 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 868 |
| 5 | Interleukin-17A Antagonist [EPC] | 683 |
| 6 | Vitamin C [EPC] | 571 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 558 |
| 8 | Aminosalicylate [EPC] | 534 |
| 9 | Vitamin B12 [EPC] | 523 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 4 | 0.0488 |
| 1 | Interleukin-17A Antagonist [EPC] | 683 | 0.0183 |
| 2 | Rifamycin Antimycobacterial [EPC] | 62 | 0.0177 |
| 3 | Adrenocorticotropic Hormone [EPC] | 13 | 0.0145 |
| 4 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 5 | Provitamin D2 Compound [EPC] | 312 | 0.0105 |
| 6 | Antiseptic [EPC] | 38 | 0.0087 |
| 7 | Diagnostic Dye [EPC] | 5 | 0.0077 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 15 | 0.0072 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 14 | 0.0068 |